US 12,138,267 B2
Methods of treating respiratory depression modulated by a non-opioid agent
Joseph Pergolizzi, Princeton, NJ (US); Thomas Miller, Princeton, NJ (US); and Alfred Schweikert, Princeton, NJ (US)
Assigned to Enalare Therapeutics Inc., Princeton, NJ (US)
Filed by Enalare Therapeutics Inc., Princeton, NJ (US)
Filed on Nov. 2, 2022, as Appl. No. 17/979,192.
Claims priority of provisional application 63/274,722, filed on Nov. 2, 2021.
Prior Publication US 2023/0140606 A1, May 4, 2023
Int. Cl. A61K 31/519 (2006.01); A61K 31/53 (2006.01); A61P 11/00 (2006.01)
CPC A61K 31/519 (2013.01) [A61K 31/53 (2013.01); A61P 11/00 (2018.01)] 8 Claims
 
1. A method of treating respiratory depression caused by a non-opioid agent comprising administering, to a patient in need thereof, an effective amount of the compound,

OG Complex Work Unit Chemistry
or a pharmaceutically effective salt thereof, wherein the non-opioid agent is propofol, or a pharmaceutically acceptable salt thereof.